Elite in Addison's Disease

Patrick A. Aubourg

Paris, FR 
Elite in Addison's Disease
Paris, FR 
OverviewLocationsClinical Research

Overview

Patrick Aubourg practices in Paris, France. Mr. Aubourg is rated as an Elite expert by MediFind in the treatment of Addison's Disease. His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Addison's Disease, Metachromatic Leukodystrophy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 25 articles and participated in 1 clinical trial in the study of Addison's Disease.

Gender
Male

Locations

Paris, France
Other Locations
France
Orsay, France
ED 569, 5 Rue Jean Baptiste Clément, Chatenay-malabry, 92290, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I/II, Open Labeled, Monocentric Study of Direct Intracranial Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human ARSA cDNA to Children With Metachromatic Leukodystrophy.
A Phase I/II, Open Labeled, Monocentric Study of Direct Intracranial Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human ARSA cDNA to Children With Metachromatic Leukodystrophy.
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
A Phase 2/3 Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
Enrollment Status: Completed
Publish Date: April 25, 2022
Intervention Type: Genetic
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

51 Total Publications

Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.
Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.
Journal: The New England journal of medicine
Published: October 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Aubourg's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile